HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuaki Hosoya Selected Research

Human Influenza (Influenza)

11/2021Detection of Variants With Reduced Baloxavir Marboxil and Oseltamivir Susceptibility in Children With Influenza A During the 2019-2020 Influenza Season.
3/2021Antiviral Effect of Favipiravir (T-705) against Measles and Subacute Sclerosing Panencephalitis Viruses.
1/2020Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season.
1/2018Immune response after a single intravenous peramivir administration in children with influenza.
1/2017Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?
12/2015Influenza A H1N1 pdm09-associated myocarditis during zanamivir therapy.
7/2015Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.
3/2015Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
7/2014Sequential influenza B viral load and susceptibility in children treated with oseltamivir and zanamivir.
6/2013Treatment with oseltamivir and prone positioning for a 9-year-old boy with ARDS caused by pandemic H1N1 2009 influenza.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuaki Hosoya Research Topics

Disease

22Infections
04/2022 - 05/2002
16Human Influenza (Influenza)
11/2021 - 05/2002
14Subacute Sclerosing Panencephalitis (SSPE)
09/2022 - 07/2003
13Proteinuria
05/2018 - 11/2006
11Hematuria
08/2018 - 08/2007
10Nephritis
10/2019 - 10/2005
10IGA Glomerulonephritis (IGA Nephropathy)
08/2018 - 11/2004
10Nephrotic Syndrome (Syndrome, Nephrotic)
05/2018 - 10/2005
8Respiratory Syncytial Virus Infections
12/2017 - 05/2002
8Glomerulonephritis
10/2016 - 03/2005
6Fever (Fevers)
12/2021 - 05/2002
6Neoplasms (Cancer)
09/2019 - 10/2005
6Purpura
01/2013 - 10/2005
5Measles
09/2022 - 07/2003
5Respiratory Tract Infections (Respiratory Tract Infection)
07/2022 - 02/2007
5Hemolytic-Uremic Syndrome
01/2022 - 01/2012
5Disease Progression
12/2021 - 02/2013
5Body Weight (Weight, Body)
07/2020 - 03/2015
5Brain Diseases (Brain Disorder)
02/2013 - 05/2005
4Obesity
06/2020 - 01/2014
4Inflammation (Inflammations)
01/2019 - 11/2003
4Liver Diseases (Liver Disease)
04/2017 - 01/2014
3Bronchopulmonary Dysplasia
10/2022 - 01/2018
3Birth Weight (Birth Weights)
10/2022 - 10/2013
3Asthma (Bronchial Asthma)
01/2022 - 02/2009
3Thrombocytopenia (Thrombopenia)
06/2021 - 10/2013
3Hyperuricemia
01/2021 - 01/2014
3Disseminated Intravascular Coagulation
04/2020 - 10/2013
3Leukemia
09/2019 - 10/2014
3Leukocytosis (Pleocytosis)
08/2019 - 05/2002
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2016 - 03/2005
3Hyperlipidemias (Hyperlipidemia)
01/2015 - 06/2007
3Hypertension (High Blood Pressure)
01/2015 - 01/2013
3Erythema elevatum diutinum
01/2013 - 06/2010
3IgA Vasculitis (Purpura, Schoenlein Henoch)
04/2011 - 03/2007
2Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 04/2021
2Respiratory Sounds (Crackle)
10/2021 - 11/2019
2Lung Diseases (Lung Disease)
01/2021 - 01/2020
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021 - 09/2020
2Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2021 - 12/2019
2Edema (Dropsy)
04/2020 - 06/2008
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2019 - 01/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2019 - 11/2011

Drug/Important Bio-Agent (IBA)

15SteroidsIBA
11/2021 - 03/2004
15Proteins (Proteins, Gene)FDA Link
12/2018 - 03/2005
11Immunoglobulin A (IgA)IBA
10/2019 - 11/2004
10Antiviral Agents (Antivirals)IBA
11/2021 - 08/2007
10Ribavirin (Virazole)FDA LinkGeneric
03/2021 - 07/2003
10CytokinesIBA
01/2018 - 05/2002
9Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 11/2003
9MethylprednisoloneFDA LinkGeneric
01/2017 - 11/2004
9Prednisolone (Predate)FDA LinkGeneric
06/2016 - 11/2004
8Pharmaceutical PreparationsIBA
03/2021 - 08/2007
8CreatinineIBA
12/2019 - 03/2005
8Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2018 - 10/2005
8mizoribineIBA
06/2016 - 11/2004
7Oseltamivir (Tamiflu)FDA Link
11/2021 - 11/2003
6InterferonsIBA
03/2021 - 08/2007
6InterleukinsIBA
01/2018 - 10/2005
6Antigen-Antibody Complex (Immune Complex)IBA
01/2016 - 03/2006
5AntibodiesIBA
06/2021 - 04/2004
5Drug CombinationsIBA
02/2018 - 01/2013
5Interleukin-6 (Interleukin 6)IBA
01/2018 - 05/2002
5Neuraminidase (Sialidase)IBA
12/2015 - 10/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015 - 05/2002
4EnzymesIBA
09/2022 - 04/2004
4AntigensIBA
04/2022 - 04/2004
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2009
4Inosine Pranobex (Imunovir)IBA
01/2019 - 08/2007
4Warfarin (Coumadin)FDA LinkGeneric
06/2016 - 11/2004
4Interferon-alpha (Interferon Alfa)IBA
04/2012 - 07/2003
3Immunoglobulin G (IgG)IBA
09/2022 - 03/2012
3Immunoglobulin E (IgE)IBA
04/2022 - 10/2005
3oxidized low density lipoproteinIBA
01/2022 - 06/2007
3Shiga Toxin (Shigella Toxin)IBA
01/2022 - 06/2015
3Intravenous Immunoglobulins (IVIG)FDA Link
06/2021 - 03/2012
3Oxygen (Dioxygen)IBA
01/2020 - 04/2004
3RNA (Ribonucleic Acid)IBA
01/2020 - 08/2003
3Complement System Proteins (Complement)IBA
02/2018 - 12/2005
3Interleukin-8 (Interleukin 8)IBA
01/2018 - 11/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 01/2012
3Zanamivir (Relenza)FDA Link
12/2015 - 07/2014
3ChemokinesIBA
12/2015 - 06/2006
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2013 - 04/2011
2Indicators and Reagents (Reagents)IBA
01/2022 - 10/2016
2LipopolysaccharidesIBA
01/2022 - 12/2019
2baloxavirIBA
11/2021 - 01/2020
2Hemoglobins (Hemoglobin)IBA
01/2021 - 03/2017
2Dacarbazine (DIC)FDA LinkGeneric
04/2020 - 10/2013

Therapy/Procedure

41Therapeutics
01/2022 - 07/2003
7Tonsillectomy
08/2018 - 11/2006
6Drug Therapy (Chemotherapy)
09/2019 - 11/2006
4Nuclear Power Plants
09/2020 - 12/2014
4Aftercare (After-Treatment)
01/2020 - 11/2014
4Hematopoietic Stem Cell Transplantation
11/2019 - 11/2011
3Plasmapheresis
01/2013 - 08/2007
2Length of Stay
07/2022 - 01/2022
2Mechanical Ventilators (Ventilator)
04/2022 - 04/2004
2Preconception Care
04/2021 - 01/2021
2Cesarean Section (Caesarean Section)
01/2021 - 11/2019